Kathrin U. Jansen — Senior Vice President & Head of Vaccine Research & Development at Pfizer | Comparably
Pfizer Claimed Company
Pfizer, a bio-pharmaceutical company, develops and manufactures human and veterinary medicines, as well as consumer healthcare products. read more
EMPLOYEE
PARTICIPANTS
768
TOTAL
RATINGS
5596
HR or Marketing? Claim Your Free Employer Account
Kathrin U. Jansen — Senior Vice President & Head of Vaccine Research & Development at Pfizer

Kathrin U. Jansen — Senior Vice President & Head of Vaccine Research & Development at Pfizer

Executive Bio

Dr. Kathrin U. Jansen, Ph.D. has been Senior Vice President of Vaccine Research & Development at Pfizer Inc. since June 01, 2015. Dr. Jansen served as Senior Vice President of Early Phase Programs of Vaccine Research at Wyeth LLC. Dr. Jansen served as Senior Vice President of Research and Development and Chief Scientific Officer of VaxGen Inc., from October 19, 2004 to July 29, 2006. Dr. Jansen lead an organization of approximately 550 colleagues comprised of clinicians, vaccine process/analytical/and formulation development, and other laboratory scientists. Dr. Jansen joined VaxGen in October 2004 after having served as Executive Director of Microbial Vaccine Research for Merck Research Laboratories. At Vaxgen, Dr. Jansen leads a team of more than 40 scientists and related personnel in developing Vaxgen's existing investigational vaccines, as well as evaluating and developing new product candidates. Dr. Jansen was the scientific leader of the team that successfully developed Merck's Phase III human papillomavirus (HPV) vaccine candidate to prevent genital warts and cervical cancer. Additionally, she was responsible for several bacterial vaccine programs at Merck. Dr. Jansen also headed the clinical assay laboratory responsible for the development and validation of new assays and for the clinical testing of all existing Merck accines and vaccine candidates. Dr. Jansen joined Merck in 1992 as a research fellow and advanced through a series of positions with increasing responsibility. Prior to Merck, she served from 1989 to 1992 as a research scientist at the Glaxo Institute for Molecular Biology, where she studied the structure and function of a low affinity receptor for IgE (CD23). Prior to her career in industry, Dr. Jansen held research positions at Cornell University and Institut fur Mikrobiologie, Marburg, Germany. She is an author on 53 scientific articles and the inventor on seven issued patents and numerous patent applications related to vaccine research and development. She holds a Ph.D. in Microbiology, with a minor in Biochemistry and Genetics and an undergraduate degree in Biology from Philipps-Universitat, Marburg, Germany.

Executive Team Culture Ratings from Pfizer Employees

TOP
30%
Pfizer's Executive Team scores in the Top 30%
of similar sized companies on Comparably
Who ranks the Executive Team the highest?
Tenure - Less than 1 Year 90/100
Department - IT 83/100
Department - HR 82/100
Who ranks the Executive Team the lowest?
Experience - 6 to 10 Years 55/100
Department - Engineering 55/100
Ethnicity - African American/Black 60/100

Pfizer's Executive Team at a Glance

Based on 330 ratings, Pfizer's employees are satisfied with their Executive Team and give them a ā€œBā€ or 71/100. On average, Women provided higher ratings for their Executive Team compared to Men. Also, the IT department thinks more highly of the Executive Team relative to the Engineering department.

Pfizer's Executive Team ranks in the Top 35% of other companies in New York and Top 30% of other companies on Comparably that also have 10,000+ Employees.

×
Rate your company